Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction

Authors not listed

University Hospital of Ferrara · 2024

Abstract

The goal of this observational study is to evaluate the presence of mitochondrial dysfunction(definition) related to oxidative stress and its possible role in frailty, with and without multimorbidity, and to identify possible frailty biomarkers correlated with mitochondrial dysfunction. The main questions it aims to answer are: * What is the role of oxidative stress-related mitochondrial dysfunction in frailty, taking into account the interaction with multimorbidity. * What could be the specific biomarkers associated with mitochondrial dysfunction in the assessment of frailty. In order to reach the study goals, we will enroll three categories of older adults: * Non-Frail without Multimorbidity (NFWoM); * Frail with Multimorbidity (FWM); * Frail without Multimorbidity (FWoM). Each individual will undergo an assessment of frailty phenotype and multimorbidity, and the collection of blood samples to isolate Peripheral Blood Mononuclear Cells (PBMCs). The identification of frailty biomarkers in each group of participants will be performed by combining untargeted metabolomics-based approaches and functional studies on specific mitochondrial dysfunctions performed on PBMCs and their subpopulations. Multivariate statistical and machine learning techniques will characterize the three clinical phenotype groups based on molecular data.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-28 MST

Cite this

APA
Anonymous. (2024). Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction. <em>University Hospital of Ferrara</em>. https://clinicaltrials.gov/study/NCT06433427
Vancouver
Anonymous. Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction. University Hospital of Ferrara. 2024.
BibTeX
@misc{anon2024Metabo, title = {Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction}, author = {Anonymous}, journal = {University Hospital of Ferrara}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings